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Abstract
Zyxin and paxillin are the prototypes of two related subfamilies of LIM domain proteins that are localized primarily at focal adhesion
plaques. However, recent work has shown that zyxin/paxillin family proteins also shuttle through the nucleus. These proteins may enter the
nucleus by association with other proteins, but are exported from the nucleus by means of intrinsic leucine-rich nuclear export sequences.
Zyxin/paxillin proteins may regulate gene transcription by interaction with transcription factors. In some cases, misregulation of nuclear
functions of zyxin/paxillin proteins appear to be associated with pathogenic effects.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Focal adhesion plaques are structures that form at the
ends of actin fibers and serve as sites for force trans-
mission. The integrins, a family of transmembrane pro-
teins, are the primary proteins at focal adhesion plaques
and function to connect the extracellular matrix to actin
filaments, although this connection also requires many
actin-attachment proteins and other cytoplasmic adhesion
proteins. Thus, proteins at focal adhesion plaques form
multiple interactions and signal transduction networks,
which regulate cell adhesion, spreading, and motility, but
which also convey signals into the nucleus to regulate gene
transcription, cell proliferation, differentiation and apopto-
sis. Major signaling molecules that transmit information
from focal adhesion plaques include FAK, Src family
kinases, MAPK, and Rho family members, among others,
which signal to the nucleus by a cascade of enzymatic
reactions [1].
In the last few years, several related LIM domain proteins
have also been implicated in the regulation of cytoskeletal
dynamics and signal transduction at focal adhesion plaques.
LIM domains are cysteine-rich motifs that are present in a
large number of proteins and they appear to be involved
primarily in protein–protein interactions. The group of LIM
domain proteins at focal adhesion plaques includes zyxin,
paxillin, and several related proteins. These proteins do not
have enzymatic domains, and their functions are likely to
depend on their roles as adaptor proteins for the assembly
of multiple protein complexes in different subcellular
compartments.
The regulation of actin dynamics, cell movement, and
signal transduction by zyxin/paxillin proteins is mediated
by their association with a variety of cytoskeletal and
signaling proteins (see Table 1) (reviewed in Refs. [2,3]).
This review will focus on emerging evidence that these
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LIM domain proteins also have functions in the
nucleus.
2. Structure and general features of zyxin and paxillin
family proteins
Zyxin/paxillin proteins have two major domains, an N-
terminal half that contains proline-rich sequences (some of
which are SH3 domain binding sites) and a C-terminal LIM
domain region (Fig. 1). The zyxin subfamily includes zyxin,
Trip6 (thyroid hormone interacting protein 6), LPP (lipoma
preferred partner), and Ajuba [2]. All zyxin family proteins
have three LIM domains towards their C termini. These
proteins share high sequence similarity, especially within the
LIM domain region.
Mammalian paxillin family members include paxillin,
Hic-5 and leupaxin [3]. As distinguished from the zyxin
subfamily, paxillin family proteins have additional protein
interaction domains within the N-terminal domain, i.e.,
multiple LD repeats, and they have four C-terminal LIM
domains. Although paxillin family members share extensive
similarity within their LIM domains and LD repeats, other
regions within their N-terminal domains are quite divergent.
3. Zyxin/paxillin proteins shuttle between focal adhesion
plaques and the nucleus
In most cell types, zyxin/paxillin proteins are detected
primarily in focal adhesion plaques at steady state. How-
ever, in some cases, these proteins have also been detected
in the cytosol or the nucleus. For example, a small fraction
of zyxin and Hic-5 can be detected in the nucleus of rat
Table 1
Interaction partners of zyxin/paxillin family proteins
Protein Cytoskeletal and/or
plasma membranea
Signaling
moleculesa
Transcription factors/
nuclear proteins
Othersa
Zyxin a-actinin Vav HPV E6 protein [22]
Mena/VASP CasL SON DNA-binding protein [32]
CRP p130Cas
H-warts/LATS1
Trip6 OpaP Grb2 Thyroid hormone receptor [15] RIL
Tropomyosin 4 PTP-BL/1E Retinoid X receptor [15] Novel protein
CasL v-Rel [17]
p130Cas gp210 [32]
Synaptic GTPase
activating protein
SON DNA-binding protein [32]
Atrophin-1 related protein [32]
LPP Mena/VASP
Ajuba Grb2 TTF1 [19]
GLT1
Paxillin h1, h3, a4 and a6
integrin subunits
FAK BPV E6 protein [33,34] Poly(A)-binding
protein 1
Syndesmos CAKh/Pyk2
Tubulin ILK
Vinculin Src
Actopaxin PKL
Schwannomin PAK
Csk
Crk
PTP-PEST
Hic-5 Vinculin FAK Androgen receptor [18]
Syndesmos CAKh/Pyk2 Glucocorticoid receptor [5]
Actopaxin PKL
Dopamine transporter Csk
PTP-PEST
GLT1
Leupaxin CAKh/Pyk2
a For a full reference list for the interacting proteins in this table, go to http://www.nf-kb.org (under Gilmore Lab Publications).
Fig. 1. Generalized structures of zyxin and paxillin family proteins. Pro,
proline-rich sequences; LD, LD repeats; NES, nuclear export signal; LIM,
LIM domains. See text for more details. Two other proteins, Testin [35] and
LIMD1 [36], have three C-terminal LIM domains related to the zyxin
family, but they do not have N-terminal proline-rich regions and thus are
not included here.
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embryo fibroblasts [4,5], and Ajuba is primarily a cytosolic
protein in mouse 3T3 cells [6].
Two lines of evidence have recently indicated that zyxin/
paxillin proteins shuttle between cytoplasmic and nuclear
compartments. First, treatment of cells with leptomycin B,
an inhibitor of Crm1-dependent nuclear export, causes
zyxin/paxillin family proteins to accumulate in the nucleus
[6–11]. Second, a leucine-rich nuclear export signal (NES)
has been identified within the N-terminal region of most
zyxin/paxillin proteins, and mutation or deletion of this NES
also results in their nuclear accumulation [4,6–10].
Although their NESs are well-characterized, less is
known about how zyxin/paxillin proteins are imported into
the nucleus. None of the zyxin/paxillin proteins has an
obvious traditional (basic) nuclear localization sequence
(NLS). Thus, these proteins either have unconventional
NLSs or nuclear import mechanisms, or they enter the
nucleus in association with other NLS-containing proteins.
Zyxin and Trip6 have multiple sequences that have nuclear
targeting functions, including sequences from both the N-
terminal domain and the C-terminal LIM domain [9,10], and
in the case of Trip6, these sequences can target a heterol-
ogous protein to the nucleus [10]. Similarly, N terminally
truncated forms of Ajuba, paxillin, and Hic-5, containing
essentially only the LIM domains, localize to the nucleus
[5,6,12,13]. That zyxin/paxillin proteins can enter the
nucleus by association with other proteins is reinforced by
the finding that a mutant form of cell adhesion kinase h/
proline-rich tyrosine kinase 2 (CAKh/PYK2) that abnor-
mally localizes to the nucleus also drags Hic-5 and paxillin
to the nucleus [14] (see also discussion of E6, below).
4. Effects of zyxin and paxillin family proteins on
transcription
LIM domains have structures related to certain zinc
fingers, which are known to mediate DNA binding in several
transcription factors. However, zyxin/paxillin proteins are
probably not direct transcription factors, as only the LIM
domains of Hic-5 have been shown to have DNA-binding
activity, and this has only been demonstrated in vitro [7].
Nonetheless, several lines of evidence indicate that zyxin and
paxillin family proteins act in the nucleus to affect tran-
scription. First, zyxin/paxillin proteins interact with a variety
of nuclear proteins (Table 1), including several transcription
factors. Second, several zyxin/paxillin proteins (zyxin, Trip6,
LPP, Hic-5) have transactivation ability when measured
in reporter gene assays, usually as GAL4 fusion proteins
[5,8,10,15,16]. In most cases, the majority of the trans-
activation activity is located within the N-terminal domain,
but the LIM domain regions also have a weak ability to
activate transcription. As zyxin/paxillin proteins essentially
consist of multiple protein–protein interaction domains, the
ability of these GAL4 fusion proteins to activate transcrip-
tion must be interpreted with some caution, in that it is
possible that GAL4 fusion proteins containing zyxin/paxillin
proteins only serve to bring interacting transcription factors
and their activation domains to the reporter loci, and thus do
not reflect an intrinsic activity of the zyxin/paxillin proteins.
Nevertheless, the bulk of evidence indicates that zyxin/
paxillin proteins regulate gene transcription as co-activators
through interaction with transcription factors or the basal
transcription machinery. Specifically, Trip6, Ajuba, and Hic-
5 have been shown to affect the activity of specific tran-
scription factors. For example, Trip6 was identified as a
protein that interacts with thyroid hormone receptor and
retinoid X receptor in a ligand-dependent manner [15], and
Trip6 can enhance the transactivation ability of the retroviral
oncoprotein v-Rel [17]. Similarly, the LIM domains of Hic-
5 interact with the androgen receptor [18] and the gluco-
corticoid receptor [5]. Moreover, overexpression of Hic-5
can enhance the transactivation activity of several steroid
receptors, including the glucocorticoid receptor, androgen
receptor, estrogen receptor, mineralocorticoid receptor, pro-
gesterone receptor, and thyroid hormone receptor [5,18];
however, the ability of Hic-5 to enhance transactivation by
the estrogen and thyroid hormone receptors also requires the
co-activator GRIP1 [5]. In each of the above cases, a simple
model is that the LIM domains of the zyxin/paxillin protein
mediate the interaction with the transcription factor and the
N-terminal domains act to enhance transcription; alterna-
tively, the multiple interaction domains of the zyxin/paxillin
proteins serve as nucleation sites for the recruitment of
multiple co-activators for these specific transcription factors.
5. Biological consequences of nuclear activities of zyxin/
paxillin proteins
Less is known about what biological functions zyxin/
paxillin proteins regulate by acting in the nucleus and how
or whether nuclear transport of zyxin/paxillin proteins is
regulated. The most tantalizing evidence suggests that these
proteins can affect steroid hormone receptor activity. As
noted above (see also Table 1), Hic-5 and Trip6 interact with
several steroid hormone receptors, in some cases, in a hor-
mone-dependent manner [5,15,18]. Furthermore, treatment
of embryonal carcinoma cells with retinoic acid causes
relocalization of Ajuba from the cytoplasm to the nucleus,
which coincides with the differentiation of these cells into an
endodermal phenotype [6]. Moreover, overexpression of the
LIM domain region of Ajuba, which accumulates in the
nucleus of these cells, induces endodermal differentiation
[6]. Finally, Ajuba interacts with the TTF-1 transcription fac-
tor, which is required for thyroid development [19]; however,
it is not known whether Ajuba affects the activity of TTF-1.
In insects, naturally occurring nuclear forms of paxillin-
related proteins appear to be involved in the control of
muscle differentiation. That is, N terminally truncated forms
of a homolog of a paxillin-like protein, which arise by
alternative splicing, have been identified in muscle cells of
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moths and Drosophila, in which they appear to be involved
in controlling an aspect of developmentally programmed
muscle cell death [20,21]. These short proteins consist of
only three LIM domains, and at least in Drosophila cells can
be detected in the nucleus [21]. It is not yet known whether
there are alternative forms of zyxin/paxillin proteins in
vertebrates that have alternative subcellular localization
due to the lack of sequences that retain the protein at focal
adhesion plaques or affect nuclear import or export.
In two situations, nuclear zyxin family sequences have
been associated with human diseases. First, Dengenhardt and
Silverstein [22] have recently shown that zyxin, via its LIM
domain region, interacts with the E6 oncoprotein of human
papillomavirus type 6, which is commonly associated with
genital warts. Moreover, the interaction with E6 causes zyxin
to move from focal adhesion plaques to the nucleus and
enhances transcriptional activation by a GAL4-zyxin pro-
tein. Second, the human LPP gene, situated at chromosomal
position 3q27-q28, is located at the junction of some disease-
related chromosomal translocations, which result in the
expression of chimeric LPP proteins. Specifically, C-termi-
nal sequences of LPP become fused either to N-terminal
sequences of the high-mobility-group protein HMGIC pro-
tein due to t(3:12) chromosomal translocations in benign
human lipomas and pulmonary chondroid hamartomas [23–
25], or to sequences of the mixed lineage leukemia (MLL)
gene product in some secondary acute leukemias due to
t(3:11) translocations [26]. In these cases, the chimeric
proteins contain HMGIC or MLL DNA-binding domains
fused to LIM domains of LPP. Moreover, the HMGIC-LPP
fusion protein is located in the nucleus [8]. Given the
common involvement of chimeric transcription factors in
human cancer [27], the LPP LIM domains may contribute a
transactivation domain or transcription factor interaction
domain to the DNA-binding sequences of HMGIC and
MLL to create novel and growth-promoting transcription
factors. In fairness, however, it should be noted that these
translocations also result in the expression of the reciprocal
cDNAs containing the N-terminal proline-rich transactiva-
tion domains of LPP fused to C-terminal sequences (e.g., of
HMGIC, MLL, or other proteins) in most of the above-
described tumors (see Ref. [28]). Therefore, at this time, it is
not known which, if any, of the LPP fusion proteins in a
given tumor contributes to the growth of that tumor.
6. Concluding remarks
Accumulating evidence suggests that zyxin/paxillin pro-
teins have nuclear functions that affect transcription (Table
2), in addition to their functions at focal adhesion plaques.
Table 2
Summary of nuclear activities of zyxin/paxillin family proteins
Protein Nuclear-cytoplasmic
shuttling
Transcriptional
activation
Co-activator
activity
DNA
binding
Zyxin + [4,9] + [10,22] ? ?
Trip6 + [10] + [10,15,16] + [17]  [10]
LPP + [8] + [8] ? ?
Ajuba + [6] ? ? ?
Paxillin + [11] ? ? ?
Hic-5 + [7] + [5] + [5,18] + [7]
Leupaxin ? ? ? ?
+, the protein has the indicated activity;  , the protein does not appear to
have the indicated activity; and ? indicates that it has not yet been
determined.
Fig. 2. Multiple functions of zyxin/paxillin proteins. At steady state, zyxin/paxillin proteins are located at focal adhesion plaques, where they interact with
various integrin, actin binding, and signaling molecules (see text and Table 1) to affect cell adhesion, motility, and signal transduction. In addition, zyxin/
paxillin proteins shuttle between cytoplasmic and nuclear compartments; the mechanism of nuclear import is not known, but nuclear export is mediated via an
intrinsic NES in these proteins. In the nucleus, zyxin/paxillin proteins are likely to interact with transcription factors to enhance gene expression.
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Indeed, zyxin/paxillin proteins may constitute a direct
signaling pathway from cytoskeletal-plasma membrane net-
works to the nucleus (Fig. 2), much as has been proposed
for the Wnt/h-catenin pathway [29], the AP-1 co-activator
JAB1 [30] and the guanylate kinase CASK [31]. Alterna-
tively, zyxin/paxillin proteins form platforms for the assem-
bly of protein complexes, both at focal adhesion plaques and
in the nucleus. It still remains to be determined what types
of physiological processes may regulate the nuclear-cyto-
plasmic shuttling of zyxin/paxillin proteins, what genes or
nuclear processes these proteins may affect, and whether
misregulation of this signaling pathway is also involved in
some diseases. The use of knockout cell lines or specific
RNAi disruptions combined with cDNA microarray data
may shed light on nuclear targets and activities of zyxin/
paxillin proteins. In any event, the study of nuclear activities
of zyxin/paxillin proteins will surely encompass an intrigu-
ing area for future study, as we unravel the complexity and
dynamics of intracellular communication.
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